ArticleFrontiers in psychology2025
Psychedelic training program development: lessons from the evolution of the EMBARK program.
Article in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ayahuasca and Its Main ComponentBiomedicines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The field of psychedelic medicine is currently developing evidence-based standards and core competencies for training providers who offer psychedelic treatments. This article contributes to this effort by describing the iterative development of the EMBARK training program. This program has been developed by Cybin, Inc. for training session monitors in clinical trials of psychedelic treatments. The EMBARK training program has been used in two successfully completed clinical trials and three ongoing trials. This article details each of the three phases of the EMBARK training program's development, including their core components, what worked well, lessons learned, and the rationale for any changes made. Innovations included in EMBARK
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.